1. Biopharma ramps up lobbying spend as drug pricing legislation nears — Roche culls two COVID-19 hopefuls amid Q1 clear-out — FDA offers scathing review of Emergent plantSee more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Beware

Discussion in 'Exact Sciences' started by anonymous, Mar 13, 2018 at 12:11 PM.

  1. anonymous

    anonymous Guest

    Lawyer up with class action suit to receive your commissions.
    Madison = arrogant lawyers at Exact. They have no idea how to run a company.